secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2023-01-10T23:59:59+00:00
Accession:  0001932393-23-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare preliminary Q4 revenue ~$4.9B (+7% YoY); 2023 organic growth guidance 5-7%
--------------------------------------------------------------------------------

- Q4 2022 revenue ~$4.9B, up ~7% YoY; organic revenue growth ~12% YoY.
- Full-year 2022 revenue ~$18.3B, up ~4% YoY; organic revenue growth ~7% YoY.
- Full-year 2022 adjusted EBIT above outlook; free cash flow toward low end of guidance.
- 2023 outlook: organic revenue growth 5-7%; adjusted EBIT margin 15.0-15.5% (up 50-100 bps).
- 2023 free cash flow conversion guidance of 85%+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239323000004/0001932393-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239323000004/gehc-20230106.htm
  HTML page:      https://secwatch.observer/filing/0001932393-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer